Optimization of Influential Variables in the Development of Buprenorphine and Bupivacaine Loaded Invasome for Dermal Delivery

Soraya Babaie ¹ , Arezou Taghvimi ², Mohammad Charkhpour ³, Amir Zarebkohan ⁴, Peyman Keyhanvar ⁵, Hamed Hamishehkar ⁶ *

Cited by CrossRef: 6

1- Ibrahim T, Abdulla N, Mohamed M. Investigating the efficacy of mirtazapine-embedded invasomal gel nanocarriers via I-optimal design for management of atopic dermatitis. Journal of Drug Delivery Science and Technology. 2024;92:105395 [Crossref]

2- Zhang Y, Yang D, Shuai B, Ding H, Yang J, Wang J, Tang L, Yao S, Zhang Y. Diclofenac sodium nanomedicine results in pain-relief and differential expression of the RNA transcriptome in the spinal cord of SNI rats. International Journal of Pharmaceutics. 2024;659:124276 [Crossref]

3- Dwivedi R, Bala R, Madaan R, Singh S, Sindhu R. Terpene-based novel invasomes: pioneering cancer treatment strategies in traditional medicine. 2024; [Crossref]

4- Babaie S, Taghvimi A, Hong J, Hamishehkar H, An S, Kim K. Recent advances in pain management based on nanoparticle technologies. J Nanobiotechnol. 2022;20(1) [Crossref]

5- Wójcik-Pastuszka D, Frąk A, Musiał W. Influence of the Acceptor Fluid on the Bupivacaine Release from the Prospective Intra-Articular Methylcellulose Hydrogel. Pharmaceutics. 2024;16(7):867 [Crossref]